Skip to Content

Join the 'Non-Small Cell Lung Cancer' group to help and get support from people like you.

Non-Small Cell Lung Cancer Support Group

Related terms: Cancer - Lung - Non-Small Cell, Lung Cancer - Non-Small Cell, NSCLC


Our support group for Non-Small Cell Lung Cancer has 59 questions and 55 members. Updated 19 Jan 2018.

Popular Questions

View more questions...

Further Information

Related Condition Support Groups

Lung Cancer

Related Drug Support Groups

methotrexate, Tarceva, Avastin, Opdivo, Keytruda, Taxol, Taxotere, Xalkori, cisplatin, view more... capecitabine, nivolumab, cyclophosphamide, Gemzar, gemcitabine, paclitaxel, erlotinib, Iressa, Tecentriq, crizotinib, pembrolizumab, Cyramza, Abraxane, bevacizumab, Navelbine, Platinol, docetaxel, Gilotrif, cetuximab, Alimta, afatinib, vinorelbine, gefitinib, ramucirumab, Methotrexate LPF Sodium, Tagrisso, Imfinzi, Mvasi, pemetrexed, osimertinib, Photofrin, Zykadia, paclitaxel protein-bound, Alunbrig, Alecensa, Portrazza, porfimer, ceritinib, necitumumab, Onxol, alectinib, atezolizumab, Docefrez, brigatinib, durvalumab, Ethyol, Platinol-AQ, Folex PFS, Trexall, amifostine

Related Condition Guides

Search this Group

Latest News

Bristol-Myers Squibb’s Opdivo (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing

PRINCETON, N.J.--(BUSINESS WIRE) March 6, 2018 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License ...

Read more news...

Latest Questions

View more questions...

Top Group Members

14,356 total answers
5 total answers
4 total answers
11,200 total answers
7,765 total answers
10 total answers

View all 55 members...

Ask a Question